Centaurus Financial, Inc. Bausch Health Companies Inc. Transaction History

Centaurus Financial, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$7.06 - $23.63 $85,073 - $284,741	-12,050 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $260,280 - $334,869	12,050 New	12,050 $275,000
Q2 2019 Aug 15, 2019	SELL	$20.52 - $26.45 $10,136 - $13,066	-494 Closed	0 $0
Q1 2019 Jul 01, 2019	SELL	$20.23 - $26.29 $395,010 - $513,338	-19,526 Reduced 97.53%	494 $20 Million
Q1 2019 May 13, 2019	BUY	$20.23 - $26.29 $388,233 - $504,531	19,191 Added 2314.96%	20,020 $494,000
Q4 2018 Feb 12, 2019	BUY	$17.64 - $28.32 $14,129 - $22,684	801 Added 2860.71%	829 $45,000
Q3 2018 Nov 05, 2018	BUY	$20.64 - $25.67 $577 - $718	28 New	28 $727,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.